{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:48:15Z","timestamp":1793933295082,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.05.033","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T22:34:02Z","timestamp":1623278042000},"page":"797-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"162","author":[{"given":"Yu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-ping","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.05.033_bb0005","first-page":"204","article-title":"Malignant and semi malignant tumors of the ovary","volume":"48","author":"Taylor","year":"1929","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.033_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0412.2010.01060.x","article-title":"Trends in incidence of borderline ovarian tumors in Denmark 1978\u20132006","volume":"90","author":"Hannibal","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2021.05.033_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ijgo.12608","article-title":"FIGO cancer report 2018","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"8","key":"10.1016\/j.ygyno.2021.05.033_bb0020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2214\/AJR.09.3936","article-title":"Current update on borderline ovarian neoplasms","volume":"194","author":"Lalwani","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.033_bb0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/cncr.20080","article-title":"Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis","volume":"100","author":"Sherman","year":"2004","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/IGC.0b013e3181991a49","article-title":"Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors)","volume":"19","author":"Fadare","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.033_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.033_bb0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00404-020-05535-0","article-title":"Significance of lymph node ratio on survival of women with borderline ovarian tumors","volume":"301","author":"Nusbaum","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-016-0276-1","article-title":"Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study","volume":"9","author":"Gokcu","year":"2016","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.033_bb0055","doi-asserted-by":"crossref","first-page":"438 e1","DOI":"10.1016\/j.ajog.2010.12.055","article-title":"Prognostic value of lymph node involvement in ovarian serous borderline tumors","volume":"204","author":"Lesieur","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13048-017-0316-5","article-title":"Identification of factors that impact recurrence in patients with borderline ovarian tumors","volume":"10","author":"Chen","year":"2017","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/IGC.0000000000000568","article-title":"The factors predicting recurrence in patients with serous borderline ovarian tumor","volume":"26","author":"Ureyen","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0090-8258(91)90331-X","article-title":"Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential","volume":"42","author":"Leake","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.033_bb0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2021.05.033_bb0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejogrb.2020.11.045","article-title":"Borderline ovarian tumors: guidelines from the French national college of obstetricians and gynecologists (CNGOF)","volume":"256","author":"Bourdel","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"70","key":"10.1016\/j.ygyno.2021.05.033_bb0085","doi-asserted-by":"crossref","first-page":"115718","DOI":"10.18632\/oncotarget.23021","article-title":"The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.033_bb0090","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2011.08.008","article-title":"Micropapillary pattern in serous borderline ovarian tumors: does it matter?","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.033_bb0095","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.033_bb0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ijgc-2018-000086","article-title":"Assessing the landscape of ovarian serous borderline tumors","volume":"29","author":"Messini","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.033_bb0105","series-title":"Sample Size Calculations in Clinical Research","first-page":"383","author":"Chow","year":"2008"},{"key":"10.1016\/j.ygyno.2021.05.033_bb0110","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-randomised Studies in Meta-Analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.ygyno.2021.05.033_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials."},{"key":"10.1016\/j.ygyno.2021.05.033_bb0120","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0 [updatedMarch2011]","author":"Higgins","year":"2011"},{"key":"10.1016\/j.ygyno.2021.05.033_bb0125","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2147\/CMAR.S287509","article-title":"Predicting lymph node involvement in borderline ovarian tumors with a quantitative model and Nomogram: a retrospective cohort study","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01443615.2018.1499076","article-title":"Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution","volume":"39","author":"Sozen","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/IGC.0000000000001154","article-title":"Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor","volume":"28","author":"Qian","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1186\/s12885-018-4932-2","article-title":"The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (<\/=40 years old) with borderline ovarian tumors","volume":"18","author":"Fang","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.033_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2017.01.019","article-title":"Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors","volume":"144","author":"Matsuo","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2021.05.033_bb0150","first-page":"5609","article-title":"The impact of surgical staging on the prognosis of mucinous borderline tumors of the ovaries: a multicenter study","volume":"37","author":"Gungorduk","year":"2017","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1245\/s10434-015-4784-9","article-title":"New pointers for surgical staging of borderline ovarian tumors","volume":"23","author":"Bendifallah","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.033_bb0160","doi-asserted-by":"crossref","first-page":"637 e1","DOI":"10.1016\/j.ajog.2014.06.028","article-title":"Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors","volume":"211","author":"Bendifallah","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.033_bb0165","first-page":"1141","article-title":"Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979\u20132006 A.D","volume":"95","author":"Sornsukolrat","year":"2012","journal-title":"J. Med. Assoc. Thail."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.033_bb0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2010.11.016","article-title":"Risk factors for recurrence of ovarian borderline tumors","volume":"120","author":"Shih","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejogrb.2009.04.031","article-title":"Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort","volume":"145","author":"Lenhard","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.033_bb0180","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.pas.0000194743.33540.e6","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.033_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000133484.92629.88","article-title":"Surgical staging of ovarian low malignant potential tumors","volume":"104","author":"Rao","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.033_bb0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/annonc\/mdg173","article-title":"Prognostic factors for patients with advanced stage serous borderline tumours of the ovary","volume":"14","author":"Morice","year":"2003","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.033_bb0200","first-page":"671","article-title":"Surgical staging in patients with ovarian tumors of low malignant potential","volume":"100","author":"Winter","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.033_bb0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T","article-title":"Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma","volume":"78","author":"Kennedy","year":"1996","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.033_bb0210","first-page":"117","article-title":"Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study","volume":"23","author":"Farthmann","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2021.05.033_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejogrb.2015.06.011","article-title":"Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection","volume":"192","author":"Kim","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:35Z","timestamp":1758772775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582100439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S009082582100439X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}